Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 1
1990 1
1991 1
1994 1
1996 1
2000 1
2002 1
2012 1
2017 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
Tournaire M, Gondry J, Mauny L, Devouche E, Morice P. Tournaire M, et al. J Gynecol Obstet Hum Reprod. 2023 Oct;52(8):102630. doi: 10.1016/j.jogoh.2023.102630. Epub 2023 Jul 13. J Gynecol Obstet Hum Reprod. 2023. PMID: 37451413
OBJECTIVES: We aimed to evaluate the risk of cervical and vaginal clear cell adenocarcinoma (CCA) in women, aged 50 years or more, exposed in utero to diethylstilbestrol (DES) and contribute to a reevaluation of the recommendations for cervical and vag …
OBJECTIVES: We aimed to evaluate the risk of cervical and vaginal clear cell adenocarcinoma (CCA) in women, aged …
Diethylstilbestrol: Potential health risks for women exposed in utero and their offspring.
Conlon JL. Conlon JL. JAAPA. 2017 Feb;30(2):49-52. doi: 10.1097/01.JAA.0000511800.91372.34. JAAPA. 2017. PMID: 28098674 Review.
DES exposure is associated with significant long-term health effects, including increased risk for breast cancer, cervical and vaginal clear cell adenocarcinoma, reproductive tract abnormalities, infertility, poor pregnancy outcomes, and early menopaus …
DES exposure is associated with significant long-term health effects, including increased risk for breast cancer, cervical and vaginal …
Clear cell adenocarcinoma of the female genital tract: long-term outcome and fertility aspects after brachytherapy aimed at a conservative treatment.
Magné N, Chargari C, Levy A, Rodriguez C, De Vos V, Gerbaulet A, Duvillard P, Morice P, Haie-Meder C. Magné N, et al. Int J Gynecol Cancer. 2012 Oct;22(8):1378-82. doi: 10.1097/IGC.0b013e318264a51d. Int J Gynecol Cancer. 2012. PMID: 22932263
OBJECTIVES: To assess the outcome and the fertility aspects in the particular population of cervical and/or vaginal clear cell adenocarcinoma (CCA) associated or not to previous in utero diethylstilbestrol exposure. ...
OBJECTIVES: To assess the outcome and the fertility aspects in the particular population of cervical and/or vaginal clear c …
Intrauterine exposure to diethylstilbestrol: long-term effects in humans.
Swan SH. Swan SH. APMIS. 2000 Dec;108(12):793-804. doi: 10.1111/j.1600-0463.2000.tb00001.x. APMIS. 2000. PMID: 11252812 Review.
This review summarizes the health effects of prenatal exposure to diethylstilbestrol (DES) and emphasizes the role of DES as the first endocrine disrupting chemical (EDC). Vaginal clear cell adenocarcinoma (CCAC), the most severe consequence of prenata …
This review summarizes the health effects of prenatal exposure to diethylstilbestrol (DES) and emphasizes the role of DES as the first endoc …
Diethylstilbestrol-associated vaginal adenosis followed by clear cell adenocarcinoma.
Sander R, Nuss RC, Rhatigan RM. Sander R, et al. Int J Gynecol Pathol. 1986;5(4):362-70. doi: 10.1097/00004347-198612000-00008. Int J Gynecol Pathol. 1986. PMID: 3643169
A young woman was examined because of a history of in utero exposure to diethylstilbestrol and was identified as having vaginal adenosis. Fourteen months later, on routine follow-up, a small vaginal clear cell adenocarcinoma was recognized. She refused …
A young woman was examined because of a history of in utero exposure to diethylstilbestrol and was identified as having vaginal adenosis. Fo …
Vaginal bleeding and diethylstilbestrol exposure during pregnancy: relationship to genital tract clear cell adenocarcinoma and vaginal adenosis in daughters.
Sharp GB, Cole P. Sharp GB, et al. Am J Obstet Gynecol. 1990 Apr;162(4):994-1001. doi: 10.1016/0002-9378(90)91303-t. Am J Obstet Gynecol. 1990. PMID: 2327468
Considering the prevalence of diethylstilbestrol exposure in the general population, the relative risks of vaginal clear cell adenocarcinoma for in utero exposure were 365.6 and 459.0 when vaginal bleeding did and did not occur during the index pregnan …
Considering the prevalence of diethylstilbestrol exposure in the general population, the relative risks of vaginal clear ce …
An evaluation of stage II vaginal clear cell adenocarcinoma according to substages.
Senekjian EK, Frey KW, Stone C, Herbst AL. Senekjian EK, et al. Gynecol Oncol. 1988 Sep;31(1):56-64. doi: 10.1016/0090-8258(88)90269-7. Gynecol Oncol. 1988. PMID: 3410356
Actuarial survival rates at 5 and 10 years for all patients with stage II vaginal clear cell adenocarcinoma were 83 and 62%, respectively. The recurrence and survival experiences for the three substage groups were similar. The data available do not sug …
Actuarial survival rates at 5 and 10 years for all patients with stage II vaginal clear cell adenocarcinoma were …
Local therapy in stage I clear cell adenocarcinoma of the vagina.
Senekjian EK, Frey KW, Anderson D, Herbst AL. Senekjian EK, et al. Cancer. 1987 Sep 15;60(6):1319-24. doi: 10.1002/1097-0142(19870915)60:6<1319::aid-cncr2820600626>3.0.co;2-h. Cancer. 1987. PMID: 3621114
Of the 219 cases of Stage I vaginal clear cell adenocarcinoma reviewed, 176 had conventional therapy and 43 underwent local therapy. ...
Of the 219 cases of Stage I vaginal clear cell adenocarcinoma reviewed, 176 had conventional therapy and 43 unde …
Late recurrences of vaginal clear cell adenocarcinoma.
Fishman DA, Williams S, Small W Jr, Keh P, Gerbie MV, Schwartz PE, Gershenson DM, Lurain JR Jr. Fishman DA, et al. Gynecol Oncol. 1996 Jul;62(1):128-32. doi: 10.1006/gyno.1996.0202. Gynecol Oncol. 1996. PMID: 8690285 Free article.
Recurrent vaginal clear cell adenocarcinoma was diagnosed in two DES-exposed patients 17 and 19 years after initial therapy. ...
Recurrent vaginal clear cell adenocarcinoma was diagnosed in two DES-exposed patients 17 and 19 years after init …
12 results